Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy

Br J Haematol. 2009 May;145(4):545-8. doi: 10.1111/j.1365-2141.2009.07642.x. Epub 2008 Mar 2.

Authors

Charles H Lawrie¹, Christopher D O Cooper, Erica Ballabio, Jianxiang Chi, Daniela Tramonti, Christian S R Hatton

Affiliation

¹ Lymphoid Malignancy Research Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK. charles.lawrie@ndcls.ox.ac.uk

PMID: 19298586
DOI: 10.1111/j.1365-2141.2009.07642.x

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

B-Lymphocytes / metabolism
Case-Control Studies
Cell Line
Gene Expression Regulation, Neoplastic*
Hematologic Neoplasms / metabolism*
Humans
MicroRNAs / biosynthesis*
Ribonuclease III / genetics
T-Lymphocytes / metabolism

Substances

MicroRNAs
DROSHA protein, human
Ribonuclease III